Recombinant Human TRIM3 Protein，His

TRIM3, a member of the tripartite motif (TRIM) family of proteins, has garnered significant attention in recent years due to its potential roles in various biological processes and diseases, particularly in cancer and neurodegenerative disorders. This protein possesses an E3 ubiquitin ligase activity, which allows it to regulate protein degradation and signaling pathways by ubiquitination. Research has shown that TRIM3 can influence cell proliferation, apoptosis, and immune responses, suggesting its involvement in tumorigenesis and the immune system. Moreover, studies indicate that dysregulation of TRIM3 expression may contribute to the pathogenesis of certain cancers and neurodegenerative diseases, such as Alzheimer's and Parkinson's. The exploration of TRIM3 as a therapeutic target is gaining momentum, with efforts directed towards understanding its molecular mechanisms and interactions with other cellular components. Using recombinant TRIM3 proteins for functional assays and structural studies could provide insights into the protein's role in vivo and lead to novel treatment strategies aimed at modulating its activity in disease contexts. Understanding TRIM3's function and regulatory mechanisms may ultimately illuminate new avenues for therapeutic intervention and enhances our understanding of cellular homeostasis in health and disease.